• FirefoxUpgrade to the new Firefox »
  •  Dow Down1.13% Nasdaq Down0.93%

    More On AZN.L

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    AstraZeneca PLC (AZN.L)

    -LSE
    4,743.50 Up 18.50(0.39%) 11:36AM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue 6,542,000   6,454,000   6,416,000   6,844,000  
    Cost of Revenue1,358,000  1,281,000  1,442,000  1,418,000  
    Gross Profit 5,184,000   5,173,000   4,974,000   5,426,000  
    Operating Expenses
    Research Development -   -   -   -  
    Selling General and Administrative -   -   -   -  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses5,486,000  4,928,000  5,101,000  5,335,000  
    Operating Income or Loss 1,056,000   1,526,000   1,315,000   1,509,000  
    Income from Continuing Operations
    Total Other Income/Expenses Net -   -   -   -  
    Earnings Before Interest And Taxes1,056,000  1,526,000  1,315,000  1,509,000  
    Interest Expense(236,000)(253,000)(141,000)(56,000)
    Income Before Tax -   -   -   -  
    Income Tax Expense69,000  69,000  132,000  (195,000)
    Minority Interest1,000  (1,000)(2,000)(4,000)
    Net Income From Continuing Ops253,000  797,000  506,000  (520,000)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 254,000   796,000   504,000   (524,000)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares -   -   -   -  

    Currency in GBp.